File type: PDF | Size: 157.91 KB
Reporting of Incidents Involving Recombinant DNA to the NIH Office of Biotechnology Activities (OBA)
The NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) states that “…any significant problems, violations of the NIH Guidelines, or any significant research-related accidents and illnesses” must be reported to NIH OBA within 30 days. Certain types of accidents must be reported on a more expedited basis. Spills or accidents in BL2 laboratories resulting in an overt exposure must be immediately reported to NIH OBA. Spills or accidents occurring in high containment (BL3 or BL4) laboratories resulting in an overt or potential exposure must be immediately reported to NIH OBA.